Béatrice Clemenceau INSERM, CNRS, Université d'Angers, Université de Nantes CRCINA Biography Publications Institution JoVE Articles Béatrice Clemenceau has not added a biography. If you are Béatrice Clemenceau and would like to personalize this page please email our Author Liaison for assistance. Publications GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR Frontiers in Immunology. 2018 | Pubmed ID: 29899740 Merkel Cell Carcinoma and Cellular Cytotoxicity: Sensitivity to Cellular Lysis and Screening for Potential Target Antigens Suitable for Antibody-dependent Cellular Cytotoxicity Cancer Immunology, Immunotherapy : CII. Aug, 2018 | Pubmed ID: 29808366 Impact on Early Outcomes and Immune Reconstitution of High-dose Post-transplant Cyclophosphamide Vs Anti-thymocyte Globulin After Reduced Intensity Conditioning Peripheral Blood Stem Cell Allogeneic Transplantation Oncotarget. Feb, 2018 | Pubmed ID: 29545911 The Doubling Potential of T Lymphocytes Allows Clinical-grade Production of a Bank of Genetically Modified Monoclonal T-cell Populations Cytotherapy. Mar, 2018 | Pubmed ID: 29396255 Adipose Cells Promote Resistance of Breast Cancer Cells to Trastuzumab-mediated Antibody-dependent Cellular Cytotoxicity Breast Cancer Research : BCR. Apr, 2015 | Pubmed ID: 25908175 The Human Natural Killer Cytotoxic Cell Line NK-92, Once Armed with a Murine CD16 Receptor, Represents a Convenient Cellular Tool for the Screening of Mouse MAbs According to Their ADCC Potential MAbs. Jul-Aug, 2013 | Pubmed ID: 23770975 Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts Ulrich Jarry*1,2, Noémie Joalland*1,2, Cynthia Chauvin*1,2, Béatrice Clemenceau1,2,3, Claire Pecqueur1,2, Emmanuel Scotet1,2 1INSERM, CNRS, Université d'Angers, Université de Nantes, CRCINA, 2Immunotherapy, Graft, Oncology, LabEx IGO, 3Hopital de Nantes, Hotel Dieu JoVE 57870 Immunology and Infection
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts Ulrich Jarry*1,2, Noémie Joalland*1,2, Cynthia Chauvin*1,2, Béatrice Clemenceau1,2,3, Claire Pecqueur1,2, Emmanuel Scotet1,2 1INSERM, CNRS, Université d'Angers, Université de Nantes, CRCINA, 2Immunotherapy, Graft, Oncology, LabEx IGO, 3Hopital de Nantes, Hotel Dieu JoVE 57870 Immunology and Infection
